Hello 2025! And "Hello!" to our new Regional Roundup, which aims to deliver the most important and timely life sciences news from around the region to your inbox every Friday. From groundbreaking research to fundraising and new development projects to who’s hiring, we bring you the top stories that matter most. Stay informed with a curated selection of the latest news, delivered directly to your inbox weekly.
As JPM kicks off, there’s a sense of cautious optimism within the industry, reflecting the tone seen over the past few years. Despite some challenges, the overall outlook remains "mostly" positive, with continued advancements and innovation driving momentum forward. That being said, our newsletter looks at Philadelphia—an ecosystem that’s making significant strides and showing a lot of promise in the life sciences space.
|
-
Penn spinout Verismo Therapeutics gets acquired by HLB Group of South Korea More
-
Traws Pharma: Financing up to $72.6 Million From Leading Healthcare Investors to Advance Small Molecule Development for H5N1 Bird Flu to Approval More
-
Penn to Receive $467M Under Settlement With BioNTech Over COVID-19 Vaccine Royalties More
-
GEMMABio: Secures $34 Million in Seed Funding to Drive Gene Therapy Advancements More
-
Galera Therapeutics: Completes Acquisition of Nova Pharmaceuticals, In Support Investors Buy $3 Million in Galera Common Stock More
-
Coeptis Therapeutics: Completes Acquisition of NexGenAI Affiliates Network and Launch of Coeptis Technologies More
-
Basel Spinout RhyGaze Closes $86 Million Series A Round to Further Novel Gene Therapy for Vision Restoration More
|
|
-
iECURE: Complete Clinical Response in First Infant Dosed With Its In Vivo Gene Editing Candidate ECUR-506 in an Ongoing Phase 1/2 Clinical Trial in Ornithine Transcarbamylase (OTC) Deficiency More
-
Annovis Bio: FDA Accepts Final Protocol for Phase 3 Alzheimer’s Study More
-
CHOP's: First of Its Kind Gene Therapy Model Offers Hope for X-Linked Sideroblastic Anemia Treatment More
-
Palvella Therapeutics: First Patients Dosed in Phase 2 TOIVA Clinical Trial for the Treatment of Cutaneous Venous Malformations More
-
Mineralys Therapeutics: Phase 2 Clinical Trial of Lorundrostat for Obstructive Sleep Apnea in Patients with Hypertension More
-
Verismo Therapeutics Doses First Patient in Phase 1 Clinical Trial of CELESTIAL-301 More
-
Passage Bio Announces Interim Data From Uplift-D Study in FTD-GRN More
-
Interius Announces German Regulatory Approval to Expand Phase 1 Clinical Trial of INT2104 More
|
|
-
Aro Biotherapeutics: Appoints Glenn Crater, MD, as Chief Medical Officer More
-
CorriXR Therapeutics: Appoints Jan Case as Chief Operating Officer More
-
GEMMABio: Appoints Dr. May Orfali as Chief Medical Officer More
-
BioBuzz Sits Down with Maurie Smith to Discuss Keystone LifeSci Collaborative's Mission to Connect and Grow a Robust Workforce More
-
Versimo Therapeutics Announces Promotion of Dr. Laura Johnson to Chief Operating Officer & Chief Scientific Officer More
-
Mark DeBisschop has Joined Vitara Biomedical as VP of Operations & manufacturing More
|
If we missed anything let us know here
|
BioBuzz Media
BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.